logo

For the Inventor, By the Inventor

Janet K Yamamoto

Gainesville, FL, United States of America

Janet K Yamamoto

This inventor holds 24 USPTO granted patents and 4 published patent applications, primarily in Vaccine Development. Top assignees: University of Florida Research Foundation Inc., University of California, Other. Active years: 1989-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janet K Yamamoto. Retrieved from https://idiyas.com/inventor/janet-k-yamamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 75.0

Average Co-Inventor Count = 1.3

ph-index = 9

Forward Citations = 196(Granted Patents)


Location History:

  • Woodland, CA (US) (1989)
  • Davis, CA (US) (1991 - 1996)
  • Hercules, CA (US) (1994 - 2000)
  • Gainesville, FL (US) (1996 - 2021)

Company Filing History:

goldMedal13 out of 3,052 
 
University of Florida Research Foundation Inc.
 patents
silverMedal8 out of 16,025 
 
University of California
 patents
bronzeMedal5 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2021

Loading Chart...
Areas of Expertise:
Immunogenic Compositions
Cross-Reactive Epitopes
FIV Vaccines
HIV Antigens
Combination Therapy
Feline Immunodeficiency Virus
T-Cell Lines
Immune Responses
24 patents (USPTO):Explore Patents
1. 11154610 - Immunogenic compositions comprising FIV and HIV gag antigens (2021-10-26),
2. 10905757 - Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats (2021-02-02),
3. 10758609 - Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats (2020-09-01),
4. 9913895 - Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats (2018-03-13),
5. 8703145 - Materials and methods for immunizing against FIV infection (2014-04-22),
6. 8182820 - Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens (2012-05-22),
7. 7658927 - Materials and methods for immunizing against FIV infection (2010-02-09),
8. 7311921 - Multi-subtype FIV vaccines (2007-12-25),
9. 7267824 - Multi-subtype FIV vaccines (2007-09-11),
10. 6875773 - Combination therapy for treatment of FIV infection (2005-04-05),
11. 6605282 - Multi-subtype FIV vaccines (2003-08-12),
12. 6544528 - Multi-subtype FIV vaccines (2003-04-08),
13. 6447993 - Multi-subtype FIV vaccines (2002-09-10),
14. 6254872 - Multi-subtype FIV vaccines (2001-07-03),
15. 6107077 - Feline lymphoid cell lines capable of producing FIV for FIV diagnostics (2000-08-22),

Title: Janet K. Yamamoto: A Pioneer in Retroviral Research and Innovation

Introduction

Janet K. Yamamoto, based in Gainesville, Florida, is a distinguished inventor with an impressive portfolio of 24 patents. With a focus on immunogenic compositions and retroviral infections, her work has significantly contributed to the fields of virology and immunology.

Latest Patents

Yamamoto's latest patents include groundbreaking inventions aimed at detecting, preventing, and treating retroviral infections in both humans and animals. One of her notable patents, titled "Immunogenic compositions comprising FIV and HIV gag antigens," reveals methods for identifying FIV, which can be transmitted from cats to humans. This invention demonstrates that FIV can infect human cells, leading to cross-reactive antibodies that can be utilized to combat both FIV and HIV infections.

Another critical patent focuses on "Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats." This invention details methods to induce immune responses against immunodeficiency viruses in animals and humans, employing conserved epitopes to enhance vaccine efficacy.

Career Highlights

In her career, Janet K. Yamamoto has worked with renowned organizations, including the University of Florida Research Foundation and the University of California. Her innovative research and patents have paved the way for advancements in the understanding and treatment of retroviral diseases, further illuminating the complexities of viral pathogenesis.

Collaborations

Yamamoto has collaborated with esteemed colleagues like Niels C. Pedersen and Barbara A. Torres. These partnerships have fostered the advancement of research in viral immunology and have contributed to the development of useful therapeutics and diagnostics.

Conclusion

Janet K. Yamamoto's prolific contributions to the field of retroviral research exemplify the profound impact an inventor can have through dedication and innovation. Her patents not only address significant challenges in treating and preventing viral infections but also lay foundational knowledge that future researchers and inventors can build upon.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…